Seppälä Laura K, Madanat-Harjuoja Laura-Maria, Leinonen Maarit K, Lääperi Mitja, Vettenranta Kim
Pediatrics, Helsinki University Hospital, 00290 Helsinki, Finland.
Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
Cancers (Basel). 2021 Oct 28;13(21):5409. doi: 10.3390/cancers13215409.
Maternal thyroid disease, especially hypothyroidism, affects pregnancy and its outcome. In-utero exposure to autoimmune thyroid disease has been reported to associate with childhood ALL in the offspring. We evaluated the risk of childhood cancer in the offspring following exposure to maternal thyroid disease in a case-control setting using registry data. All patients with their first cancer diagnosis below the age of 20 years were identified from the Finnish Cancer Registry ( = 2037) and matched for sex and birth year at a 1:5 ratio to population controls identified from the Medical Birth Registry ( = 10,185). We collected national information on maternal thyroid disease from the Medical Birth Registry, Care Register for Health Care, Register for Reimbursed Drug Purchases and Register of Special Reimbursements. We used conditional logistic regression to analyze childhood cancer risk in the offspring. The adjusted OR for any childhood cancer was 1.41 (95%, CI 1.00-2.00) comparing the offspring of mothers with hypothyroidism and those with normal thyroid function. The risk of lymphomas was increased (adjusted OR for maternal hypothyroidism 3.66, 95%, CI 1.29-10.38). The results remained stable when mothers with cancer history were excluded from the analyses. Maternal hypothyroidism appears to be associated with an increased risk for childhood lymphoma in the offspring. The association exists even after excluding possible familial cancers.
母亲甲状腺疾病,尤其是甲状腺功能减退症,会影响妊娠及其结局。据报道,子宫内暴露于自身免疫性甲状腺疾病与后代儿童期急性淋巴细胞白血病有关。我们使用登记数据,在病例对照研究中评估了后代暴露于母亲甲状腺疾病后患儿童癌症的风险。从芬兰癌症登记处识别出所有首次癌症诊断年龄在20岁以下的患者(n = 2037),并按照1:5的比例与从医疗出生登记处识别出的人群对照进行性别和出生年份匹配(n = 10,185)。我们从医疗出生登记处、医疗保健护理登记处、报销药品购买登记处和特殊报销登记处收集了关于母亲甲状腺疾病的全国性信息。我们使用条件逻辑回归分析后代患儿童癌症的风险。与甲状腺功能正常的母亲的后代相比,患甲状腺功能减退症的母亲的后代患任何儿童癌症的校正比值比为1.41(95%,CI 1.00 - 2.00)。淋巴瘤的风险增加(母亲甲状腺功能减退症的校正比值比为3.66,95%,CI 1.29 - 10.38)。当分析中排除有癌症病史的母亲时,结果仍然稳定。母亲甲状腺功能减退症似乎与后代儿童淋巴瘤风险增加有关。即使排除可能的家族性癌症,这种关联仍然存在。